BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 11713452)

  • 1. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Jawad AF; McDonald-Mcginn DM; Zackai E; Sullivan KE
    J Pediatr; 2001 Nov; 139(5):715-23. PubMed ID: 11713452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic defects in 22q11.2 deletion syndrome.
    McLean-Tooke A; Barge D; Spickett GP; Gennery AR
    J Allergy Clin Immunol; 2008 Aug; 122(2):362-7, 367.e1-4. PubMed ID: 18485468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease.
    Staple L; Andrews T; McDonald-McGinn D; Zackai E; Sullivan KE
    Pediatr Allergy Immunol; 2005 May; 16(3):226-30. PubMed ID: 15853951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between hypoparathyroidism and defective T cell immunity in 22q11.2 deletion syndrome.
    Herwadkar A; Gennery AR; Moran AS; Haeney MR; Arkwright PD
    J Clin Pathol; 2010 Feb; 63(2):151-5. PubMed ID: 20154038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
    Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
    In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Perez EE; Bokszczanin A; McDonald-McGinn D; Zackai EH; Sullivan KE
    Pediatrics; 2003 Oct; 112(4):e325. PubMed ID: 14523220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome.
    Kanaya Y; Ohga S; Ikeda K; Furuno K; Ohno T; Takada H; Kinukawa N; Hara T
    Clin Exp Immunol; 2006 Apr; 144(1):85-93. PubMed ID: 16542369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DiGeorge syndrome: new insights.
    Goldmuntz E
    Clin Perinatol; 2005 Dec; 32(4):963-78, ix-x. PubMed ID: 16325672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
    Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
    Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.
    Sullivan KE
    Immunol Allergy Clin North Am; 2008 May; 28(2):353-66. PubMed ID: 18424337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 22q11.2 deletion syndrome.
    Emanuel BS; McDonald-McGinn D; Saitta SC; Zackai EH
    Adv Pediatr; 2001; 48():39-73. PubMed ID: 11480765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary atresia with ventricular septal defect: prevalence of deletion 22q11 in the different anatomic patterns.
    Anaclerio S; Marino B; Carotti A; Digilio MC; Toscano A; Gitto P; Giannotti A; Di Donato R; Dallapiccola B
    Ital Heart J; 2001 May; 2(5):384-7. PubMed ID: 11392644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early development of immunity in diGeorge syndrome.
    Sedivá A; Bartůnková J; Zachová R; Poloucková A; Hrusák O; Janda A; Kocárek E; Novotná D; Novotná K; Klein T
    Med Sci Monit; 2005 Apr; 11(4):CR182-7. PubMed ID: 15795698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome).
    Finocchi A; Di Cesare S; Romiti ML; Capponi C; Rossi P; Carsetti R; Cancrini C
    Pediatr Allergy Immunol; 2006 Aug; 17(5):382-8. PubMed ID: 16846458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome.
    Lawrence S; McDonald-McGinn DM; Zackai E; Sullivan KE
    J Pediatr; 2003 Aug; 143(2):277-8. PubMed ID: 12970648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebral polymicrogyria and 22q11 deletion syndrome].
    Arriola-Pereda G; Verdú-Pérez A; de Castro-De Castro P
    Rev Neurol; 2009 Feb 16-28; 48(4):188-90. PubMed ID: 19226486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective IgM deficiency and 22q11.2 deletion syndrome.
    Kung SJ; Gripp KW; Stephan MJ; Fairchok MP; McGeady SJ
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):87-92. PubMed ID: 17650836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DiGeorge anomaly in the absence of chromosome 22q11.2 deletion.
    Rope AF; Cragun DL; Saal HM; Hopkin RJ
    J Pediatr; 2009 Oct; 155(4):560-5. PubMed ID: 19595366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Sullivan KE; McDonald-McGinn D; Driscoll DA; Emanuel BS; Zackai EH; Jawad AF
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):906-11. PubMed ID: 10548584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DiGeorge anomaly (CATCH 22, DiGeorge/velocardiofacial syndrome).
    Hong R
    Semin Hematol; 1998 Oct; 35(4):282-90. PubMed ID: 9801257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.